Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2015-04-30 | Dr. Rowinsky has extensive research and drug development experience, oncology expertise, and broad scientific and medical knowledge. |
Data sourced from SEC filings. Last updated: 2025-08-30